AI Article Synopsis
- - The study examined statin use in high-risk patients with atherosclerotic cardiovascular diseases at major Chinese hospitals, involving 11,783 patients from 39 hospitals across 10 cities.
- - Findings revealed that 59.6% of patients who needed statins were not prescribed the medication, and for those on statins, many had been on them for less time than they had a history of cardiovascular disease.
- - The research concluded that there is significant underuse of statins in secondary prevention for these patients, highlighting a critical issue for healthcare providers and policymakers to address quickly.
Article Abstract
Objective: To investigate the current statin use among high-risk patients with atherosclerotic cardiovascular diseases in Chinese large hospitals.
Methods: Clinical history and current medication were recorded in 11 783 patients with a history of atherosclerotic cardiovascular disease (CVD) from 39 highest-ranking hospitals in 10 Chinese cities.
Results: Indication for statin use was given for all screened patients and statin was not prescribed in up to 59.6% (7022) patients. For patients with statin use, medication time was shorter than their atherosclerotic CVD history in 1120 (23.5%) patients. The proportion of statin use among patients with ischemic stroke was 19.6%, among patients with coronary heart disease without ischemic stroke was 59.2%.
Conclusion: Statin is underused in secondary prevention among patients with atherosclerotic CVD in China. There is a large gap between guideline recommended statin use and in practice. Thus, it remains a major challenge for healthcare professionals and policy makers to resolve this problem rapidly.
Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!